Halozyme Therapeutics said on Wednesday it has agreed to acquire privately held Elektrofi in a deal worth up to $900 million ...
OTX-TKI (Axpaxli) offers a novel approach for wet macular degeneration with sustained drug release up to 9 months via a ...
Explore the Fight Retinal Blindness! Project, a global registry enhancing VEGF inhibitor treatment outcomes with ...
For this reason, over the years, I've learnt how to safely and effectively treat it in those crucial hours post-treatment.
Understanding the distribution of nanoparticles injected into a tumor can guide clinical cancer treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback